Frequent Links
Endothelial cellsVesicovaginal Fistulaoccupational health and safety ResearchAchilles tendinosis Research ArticlesMedical Journals in fluorescent markerInflammatory Syndrome Research ArticlesDevelopmental BiologyLeprosy scholarly journalsPeer-review Journals in Glucose IntoleranceTop Biomarker Related ArticlesAntiretroviral Therapy High Impact Factor JournalsOral and maxillofacial surgery Pharmacodynamics Top Open Access JournalsShort Bowel SyndromeHIV-1 Drug Resistance
Seversky XP-41
File:Seversky XP-41 061019-F-1234P-032.jpg
Seversky XP-41
The Seversky XP-41 was a fighter aircraft built in the United States in 1939. A single prototype was modified from the last production Seversky P-35 by adding a new streamlined canopy, a Wright R-1830-19 engine with a two-speed supercharger, and revised landing gear.[1] The XP-41 first flew in March 1939. The aircraft was developed in parallel with the P-43 Lancer, and work was stopped when the USAAC showed a preference for the latter.
Specifications (XP-41)
Data from[citation needed]
General characteristics- Crew: One
- Length: 27 ft 0 in (8.2 m)
- Wingspan: 36 ft 0 in (11.0 m)
- Height: 12 ft 6 in (3.8 m)
- Wing area: 219.5 ft² (20.4 m²)
- Empty weight: 5,390 lb (2,450 kg)
- Loaded weight: 6,600 lb (3,000 kg)
- Max. takeoff weight: 7,200 lb (3,273 kg)
- Powerplant: 1 × Pratt & Whitney R-1830-19 radial engine with a two-speed supercharger, 1,200 hp (895 kW)
Performance
- Maximum speed: 323 mph (517 km/h)
- Cruise speed: 292 mph (470 km/h)
- Range: 730 mi (1,168 km)
- Service ceiling: 31,500 ft (9,600 m)
- Wing loading: 30.1 lb/ft² (147.1 kg/m²)
- Power/mass: 0.18 hp/lb (0.30 kW/kg)</ul>Armament
- Guns: 1x 0.50 in machine gun and 1x 0.30 in machine gun
</ul>
See also
- Related development
- Related lists
References
- ^ "Seversky XP-41". National Museum of the United States Air Force. November 2, 2009. Retrieved 2013-10-08.
External links
16x16px Media related to Seversky XP-41 at Wikimedia Commons
| ||||||||||||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||||||